Pharmaceutical packaging can be overlooked despite manufacturers’ focus on compliance with regulations. However, mislabelling or improper packaging can pose risks for both manufacturers and users.
1. Using packaging material that is not fit for the pharmaceutical product
Pharmaceutical and medical products rely on tightly regulated packaging to maintain their curative efficacy, with rectangular boxes being common for ease of handling and stacking. Quality and robustness are paramount to safeguard fragile products during transportation. Moisture and heat must be avoided, necessitating well-defined temperature control during shipping. Insulated boxes and gel packs serve to regulate temperature for extended periods, ensuring the safe transport and stability of pharmaceutical and biopharma products.
2. Pharmaceutical packaging labelling errors
To comply with FDA regulations, involve key stakeholders, proofread, and allow time for samples. Common labelling errors include misspelt texts, wrong product names, incorrect translations, incorrect fonts, and omitted country-specific information. The most important information should appear on the most visible display panel of the package. Labels should be easy to read and understand. Container labels should be unique. Blister packs should include information about the drug, such as name, strength, and expiration date.
3. Printing inconsistencies on pharmaceutical packaging
Printing consistency is crucial, especially when it comes to packaging. In the world of marketing, packaging is the face of a product, and it plays a significant role in determining whether a product will be successful or not. Therefore, paying attention to minor printing inconsistencies and rectifying them before they become significant issues is important. By doing so, a company can protect its brand equity and avoid costly recalls that can damage its reputation.
